BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Campos-Murguía A, Ruiz-Margáin A, González-Regueiro JA, Macías-Rodríguez RU. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(39): 5919-5943 [PMID: 33132645 DOI: 10.3748/wjg.v26.i39.5919]
URL: https://www.wjgnet.com/1007-9327/full/v26/i39/5919.htm
Number Citing Articles
1
Muhammad Radzi Abu Hassan, Rosaida Hj Md Said, Zalwani Zainuddin, Haniza Omar, Siti Maisarah Md Ali, Siti Aishah Aris, Huan-Keat Chan. Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trialHeliyon 2023; 9(6): e16652 doi: 10.1016/j.heliyon.2023.e16652
2
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver DisorderCurrent Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
3
Cheng Han Ng, Kai En Chan, Mark Muthiah, Caitlyn Tan, Phoebe Tay, Wen Hui Lim, Darren Jun Hao Tan, Clarissa Elysia Fu, Jie Ning Yong, Zhen Yu Wong, Benjamin Koh, Nicholas WS Chew, Nicholas Syn, Daniel Q. Huang, Yock Young Dan, Mohammad S. Siddiqui, Arun J. Sanyal, Mazen Noureddin. Examining the interim proposal for name change to steatotic liver disease in the US populationHepatology 2023; 77(5): 1712 doi: 10.1097/HEP.0000000000000043
4
Ranyang Liu, Linlin Feng, Shuang Tang, Yin Liu, Qin Yang. The impact and mechanism of TET3 overexpression on the progression of hepatic fibrosisEpigenomics 2023; 15(10): 577 doi: 10.2217/epi-2023-0146
5
Jonathan Mertens, Luc F. Van Gaal, Sven M. Francque, Christophe De Block. NAFLD in type 1 diabetes: overrated or underappreciated?Therapeutic Advances in Endocrinology and Metabolism 2021; 12: 204201882110555 doi: 10.1177/20420188211055557
6
Jörn M Schattenberg, Quentin M Anstee, Cyrielle Caussy, Elisabetta Bugianesi, Branko Popovic. Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature reviewExpert Review of Gastroenterology & Hepatology 2021; 15(11): 1253 doi: 10.1080/17474124.2021.1974295
7
An Zhang, Xin Luo, Hong Pan, Xinxin Shen, Baocheng Liu, Dong Li, Jijia Sun. Establishment and evaluation of a risk-prediction model for hypertension in elderly patients with NAFLD from a health management perspectiveScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-18718-3
8
Gang Chen, Jun-cheng Yang, Gui-xiang Zhang, Zhong Cheng, Xiao Du. Evaluation of Six Noninvasive Methods for the Detection of Fibrosis in Chinese Patients with Obesity and Nonalcoholic Fatty Liver DiseaseObesity Surgery 2022; 32(11): 3619 doi: 10.1007/s11695-022-06251-1
9
Laura Valenzuela-Vallejo, Despina Sanoudou, Christos S. Mantzoros. Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver DiseaseJournal of Personalized Medicine 2023; 13(5): 830 doi: 10.3390/jpm13050830
10
Sung-Bum Lee, Yu-Jin Kwon, Dong-Hyuk Jung, Jong-Koo Kim. Association of Muscle Strength with Non-Alcoholic Fatty Liver Disease in Korean AdultsInternational Journal of Environmental Research and Public Health 2022; 19(3): 1675 doi: 10.3390/ijerph19031675
11
Alejandro Campos-Murguía, Berenice M Román-Calleja, José A González-Regueiro, Ivonne Hurtado-Díaz-de-León, Alberto Adrián Solís-Ortega, Nayelli C Flores-García, Ignacio García-Juárez, Astrid Ruiz-Margáin, Ricardo Ulises Macías-Rodríguez. Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19World Journal of Gastroenterology 2021; 27(33): 5502-5519 doi: 10.3748/wjg.v27.i33.5502
12
Gabriel De la Cruz-Ku, Alba Zevallos, César Ramón Rázuri-Bustamante, Sasank Kalipatnapu, Fortunato S. Príncipe-Meneses, Paola Dongo, Diego Chambergo-Michilot, Gustavo Salinas-Sedo, Bryan Valcarcel. Predictors of Nonalcoholic Steatohepatitis Severity in Obese Patients Undergoing Bariatric Surgery: A Cross-Sectional StudyBariatric Surgical Practice and Patient Care 2023; 18(4): 218 doi: 10.1089/bari.2022.0043
13
Qiang Chen, Yifeng Lou. G protein-coupled receptor 39 alleviates mitochondrial dysfunction and hepatocyte lipid accumulation via SIRT1/Nrf2 signalingJournal of Bioenergetics and Biomembranes 2023; 55(1): 33 doi: 10.1007/s10863-022-09953-4
14
Xiang-Yan Liu, Jian-Fang Lu, Li-Dong Wang, Zhuo-Yi Wang. Diagnostic value of shear wave velocity measured by virtual touch tissue imaging quantification combined with hepatic blood flow index measured by single-photon emission computed tomography first-pass method for hepatitis B fibrosisWorld Chinese Journal of Digestology 2023; 31(12): 492 doi: 10.11569/wcjd.v31.i12.492
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
15
Ritanna Curci, Antonella Bianco, Isabella Franco, Caterina Bonfiglio, Angelo Campanella, Antonella Mirizzi, Vito Giannuzzi, Raffaele Cozzolongo, Nicola Veronese, Alberto Ruben Osella. Lifestyle Modification: Evaluation of the Effects of Physical Activity and Low-Glycemic-Index Mediterranean Diet on Fibrosis ScoreNutrients 2023; 15(16): 3520 doi: 10.3390/nu15163520
16
Tracy Bonsu Osei, Anne-Marieke van Dijk, Sjoerd Dingerink, Felix Patience Chilunga, Erik Beune, Karlijn Anna Catharina Meeks, Silver Bahendeka, Matthias Bernd Schulze, Charles Agyemang, Mary Nicolaou, Adriaan Georgius Holleboom, Ina Danquah. Reduced Rank Regression-Derived Dietary Patterns Related to the Fatty Liver Index and Associations with Type 2 Diabetes Mellitus among Ghanaian Populations under Transition: The RODAM StudyNutrients 2021; 13(11): 3679 doi: 10.3390/nu13113679
17
Zheng Xu, Fan-Wei Wu, Xuan Niu, Xiao-Peng Lu, Yan-Rong Li, Shu-Ting Zhang, Jun-Zhao Ou, Xue-Mei Wang. Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic fatty liver diseasePharmaceutical Biology 2022; 60(1): 1819 doi: 10.1080/13880209.2022.2106250
18
D. V. Garbuzenko. Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver FibrosisRussian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 31(5): 16 doi: 10.22416/1382-4376-2021-31-5-16-24
19
Zahra Tolou-Ghamari, Abbas-Ali Palizban. Biomarkers, Biocatalysts, or Pathology Conditions to Evaluate Potential History of Liver Disease such as CancerClinical Cancer Investigation Journal 2022; 11(6): 31 doi: 10.51847/caGjAHyB9E
20
Iqra J Mazhar, Mohamed Yasir, Saba Sarfraz, Gandhala Shlaghya, Sri Harsha Narayana, Ujala Mushtaq, Basim Shaman Ameen, Chuhao Nie, Daniel Nechi, Sai Sri Penumetcha. Vitamin E and Pioglitazone: A Comprehensive Systematic Review of Their Efficacy in Non-alcoholic Fatty Liver DiseaseCureus 2023;  doi: 10.7759/cureus.43635
21
D.V. Garbuzenko. Non-invasive diagnosis of liver fibrosis associated with nonalcoholic steatohepatitisDokazatel'naya gastroenterologiya 2021; 10(4): 75 doi: 10.17116/dokgastro20211004175
22
Fangbin Liu, Shengnan Li, Panpan Chen, Yanqiu Gu, Shaozhan Wang, Lei Wang, Chun Chen, Rong Wang, Yongfang Yuan. Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβInternational Immunopharmacology 2023; 122: 110550 doi: 10.1016/j.intimp.2023.110550
23
Kaelee S. Brockway, Leslie Ayres, Michael J. Shoemaker. Putting It All Together: An Evidence-Based Guide to High-Intensity Interval Exercise Prescription for Patients With Complex ComorbiditiesCardiopulmonary Physical Therapy Journal 2023; 34(4): 152 doi: 10.1097/CPT.0000000000000224
24
Fei Meng, Qin Wu, Wei Zhang, Shirong Hou. Application of Interpretable Machine Learning Models Based on Ultrasonic Radiomics for Predicting the Risk of Fibrosis Progression in Diabetic Patients with Nonalcoholic Fatty Liver DiseaseDiabetes, Metabolic Syndrome and Obesity 2023; : 3901 doi: 10.2147/DMSO.S439127
25
Siarhei A. Dabravolski, Evgeny E. Bezsonov, Mirza S. Baig, Tatyana V. Popkova, Ludmila V. Nedosugova, Antonina V. Starodubova, Alexander N. Orekhov. Mitochondrial Mutations and Genetic Factors Determining NAFLD RiskInternational Journal of Molecular Sciences 2021; 22(9): 4459 doi: 10.3390/ijms22094459
26
Yacong Xiao, Xiujuan Li, Li Wang, Mingyue Hu, Youlin Liu. Proanthocyanidin A2 attenuates the activation of hepatic stellate cells by activating the PPAR-γ signalling pathwayAutoimmunity 2023; 56(1) doi: 10.1080/08916934.2023.2250101
27
Rui Zhang, Quanwei Zhang, ZiYi Cui, BenZeng Huang, Haitian Ma. Dimethyl fumarate restores Ca2+ dyshomeostasis through activation of the SIRT1 signal to treat nonalcoholic fatty liver diseaseLife Sciences 2024; 341: 122505 doi: 10.1016/j.lfs.2024.122505
28
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Ji Hye Kim, Byung-gyu Kim, Bokyung Lee, Sung Mun Bae, Eun-Kyung Kim. AGL9: A Novel Hepatoprotective Peptide from the Larvae of Edible Insects Alleviates Obesity-Induced Hepatic Inflammation by Regulating AMPK/Nrf2 SignalingFoods 2021; 10(9): 1973 doi: 10.3390/foods10091973
29
María C. Brañes, Raimundo Gillet, Rodrigo Valenzuela. Efficacy of Submicron Dispersible Free Phytosterols on Non-Alcoholic Fatty Liver Disease: A Pilot StudyJournal of Clinical Medicine 2023; 12(3): 979 doi: 10.3390/jcm12030979
30
Anna Kleczka, Bogdan Mazur, Krzysztof Tomaszek, Andrzej Gabriel, Radosław Dzik, Agata Kabała-Dzik. Association of NK Cells with the Severity of Fibrosis in Patients with Chronic Hepatitis CDiagnostics 2023; 13(13): 2187 doi: 10.3390/diagnostics13132187